The Strategy Research On Risk Investment Introduced Into Chinese Biological Medicine Industry In New Economic Period

Under the macroeconomic background where new-economy is becoming the leading economic model, the function of hi-tech industry has been constantly intensified. In the medicine industry, it is clearly showed by the emergency and development of modern pharmacy industry and the markedly improved role of the bio-pharmacy industry in the whole medicine industry. In order to push up the development of bio-pharmacy industry, some necessary sustaining tactics and the assistance of tools system are badly needed. From this aspect, investment, usually in large number and high risk of hi-tech (especially in technological innovation and industrialization) is important for the development of medicine industry. Whether the risk investment system has been perfected or not, the level of its development has become an important factor affecting the development of the hi-tech industry including bio-pharmacy production industry. This is also the starting-point of the study in this article and the basic theory point of discussing problem.This article analyzes the characteristic of bio-pharmacy industry under the new-economy background in details; The development state of domestic and foreign bio-medicine industry, the disequilibrium development in different region and existing problem; The impact with the entry of WTO brought about to Chinese bio-medicine industry and the opportunities and challenges that industrialization of our bio-medicine will face, the real significance that perfect risk investment system will promote the development of our country and even the whole bio-medicine industry. On this basis, the selection of risk investment evaluating model and risk tactics which can ensure the effective consistency of risk investment and bio-medicine industry is analysed in details in this article.According to this article, the following aspects are the important tacticsguarantee and the starting-point of policy decision:1. The demand of R&D cost and the high return of profit are the focus of risk investment. Innovation is the key which medicine enterprises use for beneficial competitive position. But research and development of new medicine, the industrialization and large-scale production need large number of capital investment as support. This provides good chance and necessity for the participation of risk investment.2. Advancement, maturity and market of the technology are important foundation for selecting the investment item and important content of feasibility evaluation.3. Speed and scale are the economic principles with which risk investment must comply. The main reason is that if the achievement of a hi-tech cannot bring about industrialization and large-scale production quickly in proper interval, it will be confronted by substitution or obsolescence.